412 related articles for article (PubMed ID: 22380774)
1. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
Kathiravan MK; Kale AN; Nilewar S
Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
[TBL] [Abstract][Full Text] [Related]
5. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
Tse-Dinh YC
Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
[TBL] [Abstract][Full Text] [Related]
6. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
You F; Gao C
Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase inhibitors as anticancer agents: a patent update.
Khadka DB; Cho WJ
Expert Opin Ther Pat; 2013 Aug; 23(8):1033-56. PubMed ID: 23611704
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Liang X; Wu Q; Luan S; Yin Z; He C; Yin L; Zou Y; Yuan Z; Li L; Song X; He M; Lv C; Zhang W
Eur J Med Chem; 2019 Jun; 171():129-168. PubMed ID: 30917303
[TBL] [Abstract][Full Text] [Related]
11. Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives.
Wang YC; Qian C; Peng ZL; Hou XJ; Wang LL; Chao H; Ji LN
J Inorg Biochem; 2014 Jan; 130():15-27. PubMed ID: 24145066
[TBL] [Abstract][Full Text] [Related]
12. Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
Casu L; Cottiglia F; Leonti M; De Logu A; Agus E; Tse-Dinh YC; Lombardo V; Sissi C
Bioorg Med Chem Lett; 2011 Dec; 21(23):7041-4. PubMed ID: 22014547
[TBL] [Abstract][Full Text] [Related]
13. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
[TBL] [Abstract][Full Text] [Related]
15. Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase.
Ehmann DE; Lahiri SD
Curr Opin Pharmacol; 2014 Oct; 18():76-83. PubMed ID: 25271174
[TBL] [Abstract][Full Text] [Related]
16. Drugging topoisomerases: lessons and challenges.
Pommier Y
ACS Chem Biol; 2013 Jan; 8(1):82-95. PubMed ID: 23259582
[TBL] [Abstract][Full Text] [Related]
17. Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
Basarab GS; Manchester JI; Bist S; Boriack-Sjodin PA; Dangel B; Illingworth R; Sherer BA; Sriram S; Uria-Nickelsen M; Eakin AE
J Med Chem; 2013 Nov; 56(21):8712-35. PubMed ID: 24098982
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system.
Kennedy S; DiCesare JC; Sheaff RJ
Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415
[TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
Sanyal G; Doig P
Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]